Skip to main content
SpringerLink
Log in

Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland

  • Rapid Communication
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Ghrelin has been proposed as a natural ligand of the GH secretagogue receptor(s) (GHS-R), which was an orphan receptor activated by synthetic peptidyl (hexarelin) and non-peptidyl (MK-0677) GHS to strongly release GH in animals and humans. Herein we studied: I) the binding of 125I-labeled human ghrelin to membranes from human hypothalamus and pituitary gland; 2) the ability of human ghrelin (either octanoylated or desoctanoylated), as well as of some GHS and neuropeptides to compete with the radioligand. The saturation binding analysis showed, in both tissues, the existence of a single class of high-affinity binding sites with limited binding capacity. The Bmax (maximal number of binding sites) values of ghrelin receptors in the hypothalamus were significantly greater (p<0.001) than those detected in the pituitary, whereas the Kd (dissociation constant) values in the two tissues were similar. 125I-ghrelin bound to hypothalamic membranes was displaced by ghrelin, hexarelin, MK-0677, various GHS antagonists (EP-80317, [D-Arg1-D-Phe5-D-Trp7,9-Leu11]-substance P) and some natural (cortistatin-14) and synthetic (vapreotide) SRIH-14 agonists. In contrast, no competition was seen in the presence of GHRH-44, SRIH-14 or desoctanoylated ghrelin, a ghrelin precursor that is devoid of GH-releasing properties. In conclusion, this preliminary study firstly demonstrates that ghrelin needs octanoylation to bind its hypothalamo-pituitary receptors. These receptors are the specific binding sites for GHS and their antagonists, as well as for SRIH analogs (vapreotide and cortistatin-14), but not for native SRIH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kankawa K. Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656–660.

    Article  CAS  PubMed  Google Scholar 

  2. Arvat E., Di Vito L., Broglio F., Papotti M., Muccioli G., Dieguez C., Casanueva F., Deghenghi R., Camanni F., Ghigo E. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J. Endocrinol. Invest. 2000, 23: 493–495.

    Article  CAS  PubMed  Google Scholar 

  3. Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., Papotti M., Muccioli G., Dieguez C., Casanueva F., Deghenghi R., Camanni F., Ghigo E. Endocrine activities of ghrelin, a natural GH secretagogue, in humans: comparison and interactions with hexarelin, a non natural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab. 2001, in press.

    Google Scholar 

  4. Seoane L.M., Tovar S., Baldelli R., Arvat E., Ghigo E., Casanueva F.F., Dieguez C. Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur. J. Endocrinol. 2000, 143: R7–R9.

    Article  CAS  PubMed  Google Scholar 

  5. Ghigo E., Arvat E., Muccioli G., Camanni F. Growth hormone-releasing peptides. Eur. J. Endocrinol. 1997, 136: 445–460

    Article  CAS  PubMed  Google Scholar 

  6. Smith R.G., Van der Ploeg L.H.T., Howard A.D., Feighner S.D., Cheng K., Hickey G.J., Wyvratt M.J., Fisher M.H., Nargund R.P., Patchett A.A. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 1997, 18: 621–645.

    Article  CAS  PubMed  Google Scholar 

  7. Papotti M., Ghè C., Cassoni P., Catapano F., Deghenghi R., Ghigo E., Muccioli G. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab. 2000, 85: 3803–3807.

    CAS  PubMed  Google Scholar 

  8. Muccioli G., Ghè C., Ghigo M.C., Papotti M., Arvat E., Boghen M., Nilsson M., Deghenghi R., Ong H., Ghigo E. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol. 1998, 157: 99–106.

    Article  CAS  PubMed  Google Scholar 

  9. Bowers C.Y., Reynolds G.A., Kang Chang J. Unnatural GHRP and natural ghrelin linkage. Proc. of the 82th Annual Meeting of the Endocrine Society, June 21–24, 2000, Toronto, Canada (Abstract 689).

    Google Scholar 

  10. Deghenghi R. Diazaspiro, azepino and azabicyclo therapeutic peptides. United States Patent, 2000 6, 925, 471.

    Google Scholar 

  11. Bitar K.G., Bowers C.Y., Coy D.H. Effect of substance P/bombesin antagonists on the release of growth hormone by GHRP and GHRH. Biochem. Biophys. Res. Commun. 1991, 180: 156–161.

    Article  CAS  PubMed  Google Scholar 

  12. Spier A.D., de Lecea L. Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res. Rev. 2000, 33: 228–241.

    Article  CAS  PubMed  Google Scholar 

  13. Deghenghi, R., Papotti, M., Locatelli, V., Ghigo, E., Muccioli G. Somatostatin octapeptides (lanreotide, octreotide, vapreotide and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland. Third International Symposium on Growth Hormone Secretagogues, February 17–19, 2000, Keystone, CO. Endocrine 2001, in press.

    Google Scholar 

  14. Deghenghi R., Papotti M., Ghigo E., Muccioli G. Cortistatin, but not somatostatin, binds to growth hormone secretagogue receptors of human pituitary gland. J. Endocrinol. Invest. 2001, in press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Farmacologia, Dipartimento di Anatomia, Farmacologia e Medicina Forense, Università di Torino, Via P. Giuria 13, 10125, Torino, Italy

    G. Muccioli

  2. Department of Biomedical Sciences and Oncology, University of Turin, Turin, Italy

    M. Papotti

  3. Division of Endocrinology, Department of Internal Medicine, University of Turin, Turin, Italy

    E. Ghigo

  4. Department of Pharmacology, University of Milan, Milan, Italy

    V. Locatelli

  5. Europeptides, Argenteuil, France

    R. Deghenghi

Authors
  1. G. Muccioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Papotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Locatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Ghigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Deghenghi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Muccioli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muccioli, G., Papotti, M., Locatelli, V. et al. Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J Endocrinol Invest 24, RC7–RC9 (2001). https://doi.org/10.1007/BF03343831

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343831

Key-words

Search

Navigation